Invention Grant
US09573949B2 Derivatives of [1, 2, 4] triazolo [4, 3-a] pyridine as P38—MAP kinase inhibitors
有权
[1,2,4]三唑并[4,3-a]吡啶的衍生物作为P38-MAP激酶抑制剂
![Derivatives of [1, 2, 4] triazolo [4, 3-a] pyridine as P38—MAP kinase inhibitors](/docs/US/2017-02-21/US09573949B2/abs.jpg.600x600.jpg)
- Patent Title: Derivatives of [1, 2, 4] triazolo [4, 3-a] pyridine as P38—MAP kinase inhibitors
- Patent Title (中): [1,2,4]三唑并[4,3-a]吡啶的衍生物作为P38-MAP激酶抑制剂
-
Application No.: US14895718Application Date: 2013-06-06
-
Publication No.: US09573949B2Publication Date: 2017-02-21
- Inventor: Lilian Alcaraz , Terry Aaron Panchal , Andrew Stephen Robert Jennings , Andrew Peter Cridland , Christopher Hurley
- Applicant: CHIESI FARMACEUTICI S.P.A.
- Applicant Address: IT Parma
- Assignee: Chiesi Farmaceutici S.p.A.
- Current Assignee: Chiesi Farmaceutici S.p.A.
- Current Assignee Address: IT Parma
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- International Application: PCT/EP2013/061706 WO 20130606
- International Announcement: WO2014/194956 WO 20141211
- Main IPC: A61K31/437
- IPC: A61K31/437 ; C07D471/04 ; C07D519/00
![Derivatives of [1, 2, 4] triazolo [4, 3-a] pyridine as P38—MAP kinase inhibitors](/abs-image/US/2017/02/21/US09573949B2/abs.jpg.150x150.jpg)
Abstract:
Mitogen activated protein kinase (MAPK) inhibitors disclosed herein are useful for the treatment of diseases of the respiratory tract, such as chronic eosinophilic pneumonia, asthma, COPD, adult respiratory distress syndrome (ARDS), exacerbation of airways hyper-reactivity consequent to other drug therapy, and airways disease that is associated with pulmonary hypertension.
Public/Granted literature
- US20160108040A1 DERIVATIVES OF [1, 2, 4] TRIAZOLO [4, 3 - A] PYRIDINE AS P38 - MAP KINASE INHIBITORS Public/Granted day:2016-04-21
Information query
IPC分类:
